Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK and Safety of Halix Albuterol DPI vs MDI in Healthy Volunteers
NCT03373409Phase 1Completed
- Sponsor
- Concentrx Pharmaceuticals, Inc.
- Start
- Nov 2017
- Primary completion
- May 2018
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of albuterol dry powder inhaler in asthma (3 arms), sponsored by Concentrx Pharmaceuticals, Inc. Primary endpoint: Forced Expiratory Volume in 1 second. Started Nov 2017; status: completed.
02
Drugs
albuterol dry powder inhaler
03
Conditions
asthma
Beyond the preview
Go deeper on NCT03373409.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03373409.